US Patent Issued to University of Manitoba on July 29 for "Dendritic cell-targeting universal vaccine for influenza infection" (Canadian Inventor)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,254, issued on July 29, was assigned to University of Manitoba (Winnipeg, Canada).

"Dendritic cell-targeting universal vaccine for influenza infection" was invented by Xiao-Jian Yao (Winnipeg, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "We have recently developed a novel DC-targeting vaccine platform using Ebola glycoprotein (EboGP) DC-targeting domain-based fusion protein technology. Here, we will use this technology to generate universal vaccines against Influenza A by fusing a DC-targeting/activation domain (EboGPAM), derived from EboGP to I) a tetrameric conserved extracellular domain of M2 (M2e) of Influenza A strains from human, bird...